Altesa BioSciences Closes Oversubscribed $75 Million Series B Financing to Transform Treatment of Chronic Lung Diseases
-Financing led by Forbion, joined by Sanofi and existing investors Medicxi, Pitango, and Atlantic Partners--Proceeds to advance vapendavir, a first-in-class...

Altesa BioSciences Closes Oversubscribed $75 Million Series B Financing to Transform Treatment of Chronic Lung Diseases
ImmunityBio to launch ANKTIVA for bladder, lung cancer
Medical Recruitment Market: The Talent Crisis Reshaping Healthcare
Foothills Medical Centre offering new minimally invasive treatment for lung clots – DiscoverAirdrie.com